AKT1 and hepatocellular carcinoma: To get insights into the molecular mechanisms underlying the superior efficacy of palbociclib/regorafenib combination, we analyzed its effects on the activation/expression of cell cycle regulatory proteins along with components of the AKT and MAPK signaling pathways in all three HCC cell models.